A new report from the Chief China Economist’s Office examines Hong Kong’s role as a fundraising centre for Mainland MPEs.

The product offers investors one more tool to capture short-term profit potential in a bearish market.

The HKEX Chief China Economist’s Office and China Exchanges Services Company have jointly published a research report looking at the state of Biotech investment globally and the options available for biotech investors.

Chief Executive Charles Li looks at one year of the new Listing Regime, and what’s coming next.

See the highlights of HKEX’s financial performance in the first three months of 2019.

One year ago HKEX ushered in the biggest changes to the Listing Rules in a quarter century. Here are some highlights from year one.